MabVax Therapeutics Holdings, Inc. (MBVXQ) Financial Statements (2024 and earlier)

Company Profile

Business Address 11535 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5941,0568863,0531,847597
Cash and cash equivalents5941,0568863,0531,847597
Prepaid expense3113915030461199
Other current assets1431531711188910
Total current assets:7681,3481,2083,4751,997806
Noncurrent Assets
Property, plant and equipment498538578619664686
Intangible assets, net (including goodwill)6,8266,8266,8266,8266,8266,826
Goodwill6,8266,8266,8266,8266,8266,826
Other noncurrent assets179179179179169337
Other undisclosed noncurrent assets  0    
Total noncurrent assets:7,5027,5437,5837,6247,6597,850
TOTAL ASSETS:8,2718,8908,79011,0999,6558,655
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,9873,9343,1113,8374,4154,076
Interest and dividends payable723639424651
Employee-related liabilities343393312742639704
Accounts payable1,9791,1021,0911,5502,0871,724
Accrued liabilities2,5932,4041,6691,5031,6431,597
Debt1,6852,5421,7001,7111,6841,684
Other undisclosed current liabilities1,05669995846958994
Total current liabilities:7,7296,5455,8066,3937,0576,754
Noncurrent Liabilities
Long-term debt and lease obligation9121,3181,6672,0082,3442,667
Long-term debt, excluding current maturities8761,2761,6211,9582,2852,603
Capital lease obligations364146505964
Liabilities, other than long-term debt197194186177167157
Other liabilities197194186177167157
Total noncurrent liabilities:1,1091,5121,8542,1852,5112,824
Other undisclosed liabilities 1     
Total liabilities:8,8388,0567,6608,5789,5689,578
Equity
Equity, attributable to parent, including:(567)8341,1302,52087(923)
Common stock9390691899263
Additional paid in capital118,023115,410112,105103,34994,80382,623
Accumulated deficit(118,691)(114,674)(111,054)(101,047)(94,846)(83,617)
Other undisclosed equity, attributable to parent981029388
Other undisclosed equity (1)     
Total equity:(567)8341,1302,52087(923)
TOTAL LIABILITIES AND EQUITY:8,2718,8908,79011,0999,6558,655

Income Statement (P&L) ($ in thousands)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
Revenues700     
Cost of revenue      
Gross profit:700     
Operating expenses(3,170)(3,435)(4,389)(2,849)(5,741)(5,092)
Operating income (loss):(2,470)(3,435)(4,389)(2,849)(5,741)(5,092)
Nonoperating expense
(Other Nonoperating expense)
(158)(186)(207)(231)(249)(263)
Interest and debt expense(102) (483)(139)(151)(157)
Income (loss) from continuing operations:(2,730)(3,621)(5,079)(3,219)(6,141)(5,512)
Income (loss) before gain (loss) on sale of properties:(2,730)(3,621)(5,079)(3,219)(6,141)(5,512)
Net income (loss):(2,730)(3,621)(5,079)(3,219)(6,141)(5,512)
Other undisclosed net income attributable to parent102 483139151157
Net income (loss) attributable to parent:(2,628)(3,621)(4,596)(3,080)(5,990)(5,355)
Other undisclosed net loss available to common stockholders, basic (1,388) (5,411)(3,120)(5,239) 
Net income (loss) available to common stockholders, diluted:(4,016)(3,621)(10,007)(6,200)(11,229)(5,355)

Comprehensive Income ($ in thousands)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
Net income (loss):(2,730)(3,621)(5,079)(3,219)(6,141)(5,512)
Comprehensive income (loss), net of tax, attributable to parent:(2,730)(3,621)(5,079)(3,219)(6,141)(5,512)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: